arrow
M

Mario Silva

Universidad Nacional Autonoma de Mexico
H指数:40
被引数:6,334

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program

4-IN-THE-LUNG-RUN肺癌筛查项目第一年意外发现的临床紧迫性

2026-06-280
OA
AI Performance for Nodule Volume Doubling Time in the follow-up of the UKLS Lung Cancer Screening Study Compared to Expert Consensus and Histological Validation

AI在UKLS肺癌筛查研究中用于结节体积倍增时间的随访表现,与专家共识及组织学验证的比较

2025-11-220
OAAI
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

EORTC 1417 - REACTION:一项关于依托泊苷联合顺铂/卡铂,并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究

2025-10-300
PRE
Lung cancer screening with low-dose CT: definition of positive, indeterminate, and negative screen results. A nodule management recommendation from the European Society of Thoracic Imaging

低剂量CT肺癌筛查:阳性、不确定和阴性筛查结果定义。欧洲胸部分层影像学会结节管理建议

2025-07-010
OAAI
Aggressiveness-guided nodule management for lung cancer screening in Europe—justification for follow-up intervals and definition of growth

基于侵袭性引导的肺结节管理在欧洲肺癌筛查中的应用——随访间隔的合理性与生长定义的界定

2025-07-010
OAAI
Prior knowledge-guided vision-transformer-based unsupervised domain adaptation for intubation prediction in lung disease at one week
2024-12-010
OAAI
Study rationale and design of the PEOPLHE trial
2024-02-061
OAAI
Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis
2023-11-064
OA